Does endometriosis increase the risks of endometrial hyperplasia and endometrial cancer?

医学 子宫内膜癌 子宫内膜异位症 危险系数 子宫内膜增生 妇科 人口 比例危险模型 非典型增生 产科 癌症 置信区间 肿瘤科 内科学 环境卫生
作者
Hoon Kim,Hyun Jung Kim,Hyeong Sik Ahn
出处
期刊:Gynecologic Oncology [Elsevier]
卷期号:169: 147-153 被引量:11
标识
DOI:10.1016/j.ygyno.2022.06.021
摘要

The risk of developing endometrial hyperplasia after diagnosis of endometriosis has not been determined. Moreover, the risk of endometrial cancer associated with endometriosis is unclear. This nationwide population-based study investigated the associations of endometrial hyperplasia and endometrial cancer with endometriosis, after adjusting for covariates.This population-based observational study analyzed data from the Korean National Health Insurance (NHI) database, including 147,869 women who were diagnosed with endometriosis from 2002 to 2017, with each patient matched to 20 control women without endometriosis. Cox proportional hazard regression analyses were performed to estimate the hazard ratios (HRs) of endometrial hyperplasia, endometrial cancer, and mortality from endometrial cancer.Among three million women in this population, 16,377 women were diagnosed with endometrial hyperplasia, and 1795 women were diagnosed with endometrial cancer over 19,931,794 person-years of follow-up. Women with endometriosis were at significantly higher risks of endometrial hyperplasia (adjusted hazard ratio [aHR] 1.85, 95% confidence interval [CI] 1.75-1.95), and endometrial cancer (aHR 1.35, 95% CI 1.12-1.63) were compared with control women after adjustment for covariates. A diagnosis of endometriosis did not affect survival in patients with endometrial cancer.The risks of endometrial hyperplasia and endometrial cancer were found to be significantly higher in women with than without endometriosis. The presence of endometriosis did not affect overall survival in women with endometrial cancer. Additional long-term prospective studies with adequate control of confounders are needed.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
仙笛童神完成签到,获得积分10
1秒前
why359发布了新的文献求助10
2秒前
搜集达人应助blUe采纳,获得10
3秒前
善学以致用应助魏铭哲采纳,获得10
3秒前
LHQ完成签到 ,获得积分10
3秒前
Maestro_S应助居里姐姐采纳,获得10
3秒前
4秒前
4秒前
wangying发布了新的文献求助10
5秒前
5秒前
淡然亦巧完成签到,获得积分10
6秒前
6秒前
7秒前
翎儿响叮当完成签到,获得积分10
9秒前
迷路的猎豹完成签到,获得积分10
9秒前
123发布了新的文献求助10
9秒前
猫小乐C完成签到,获得积分10
9秒前
10秒前
10秒前
10秒前
之之碰发布了新的文献求助10
10秒前
哈基米发布了新的文献求助10
11秒前
11秒前
兔兔完成签到 ,获得积分10
11秒前
可爱丸子完成签到,获得积分10
12秒前
萱瑄爸爸完成签到,获得积分10
13秒前
13秒前
13秒前
marmota完成签到,获得积分10
13秒前
ling完成签到,获得积分10
14秒前
15秒前
情怀应助Sulfur采纳,获得10
16秒前
欢欢发布了新的文献求助30
16秒前
Tonyks发布了新的文献求助10
17秒前
18秒前
失眠的丹翠完成签到,获得积分10
19秒前
peek1ove发布了新的文献求助10
19秒前
kk131完成签到,获得积分10
19秒前
han应助小哀采纳,获得10
19秒前
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Kinesiophobia : a new view of chronic pain behavior 3000
3O - Innate resistance in EGFR mutant non-small cell lung cancer (NSCLC) patients by coactivation of receptor tyrosine kinases (RTKs) 1000
Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics 900
Signals, Systems, and Signal Processing 510
Discrete-Time Signals and Systems 510
Proceedings of the Fourth International Congress of Nematology, 8-13 June 2002, Tenerife, Spain 500
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5932769
求助须知:如何正确求助?哪些是违规求助? 6999346
关于积分的说明 15853748
捐赠科研通 5061608
什么是DOI,文献DOI怎么找? 2722616
邀请新用户注册赠送积分活动 1679771
关于科研通互助平台的介绍 1610571